ABT-751
N/A
Report date: 2022/07/04 19:38:02
NME
Base Information
Drug NameABT-751
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[16]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[9]
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesEisai Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesAbbott LaboratoriesNational Institutes Of Health Clinical Center (Cc)National Cancer Institute +[5]
Active IndicationsN/A
Inactive Indications +[16]
Other Information
ATC CodeN/A
Related LinksN/A